- Active not recruitingPHASE3
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
This study is looking at a new way to give a medicine called isatuximab for a type of blood cancer called multiple myeloma. It compares giving the medicine as a shot under the skin versus through a drip into a vein, always with other standard treatments.
For: Plasma Cell Myeloma RecurrentUnited States · Argentina · Australia - AuthorisedTherapeutic confirmatory (Phase III)
Montelukast as disease modifying treatment in mild-moderate Parkinson’s disease, an open-label, phase II extension trial (MONTPARK_OLE)
This study is looking into montelukast, a drug normally used for asthma, to see if it can help people with Parkinson's disease. We want to understand how safe it is and how well people tolerate it, building on earlier research.
For: Parkinson's DiseaseSweden